Label: COCOKIND POSTBIOTIC ACNE SERUM- salicylic acid 1.5% liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 11, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient



    Salicylic acid 1.5%.

  • Purpose

    Acne treatment

  • Use

    For the treatment of acne.

  • Warnings


    For external use only.​

  • When using this product



    When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

  • Keep out of reach of children



    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    • Gently massage or pat 2-3 drops of serum onto clean skin, avoiding eye area

    • Use am and pm.

    • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor.

    • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

  • Inactive ingredients

    Aloe barbadensis leaf juice, propanediol, glycerin, sodium citrate, musa sapientum (banana) fruit extract, gluconolactone, lysolecithin, sclerotium gum, maltodextrin, sodium benzoate, sodium hydroxide, pullulan, xanthan gum, lactobacillus ferment, tocopherol, silica, helianthus annuus (sunflower) seed oil, calcium gluconate, beta-glucan, 1,2-hexanediol, caprylyl glycol, pyrus malus (apple) fruit extract, morinda citrifolia fruit extract.

  • Cocokind postbiotic acne serum

    Label

  • INGREDIENTS AND APPEARANCE
    COCOKIND POSTBIOTIC ACNE SERUM 
    salicylic acid 1.5% liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:79356-210
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID1.5 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    PULLULAN (UNII: 8ZQ0AYU1TT)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    SUNFLOWER OIL (UNII: 3W1JG795YI)  
    CALCIUM GLUCONATE (UNII: SQE6VB453K)  
    APPLE (UNII: B423VGH5S9)  
    MORINDA CITRIFOLIA FRUIT (UNII: 7829X3G2X5)  
    BETASIZOFIRAN (UNII: 2X51AD1X3T)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SODIUM CARBOXYMETHYL .BETA.-GLUCAN (DS 0.65-0.85) (UNII: 2YGO1190AP)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    BANANA (UNII: 4AJZ4765R9)  
    LACTOBACILLUS FERMENTUM (UNII: 2C1F12C6AP)  
    GLUCONOLACTONE (UNII: WQ29KQ9POT)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    LYSOPHOSPHATIDYLCHOLINE, SOYBEAN (UNII: CQD833204Z)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:79356-210-101 in 1 CARTON01/10/2022
    130 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00601/10/2022
    Labeler - Onekind.25 (080286020)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!